Phase II Trials Of Covaxin To Begin Tomorrow: Report
New Delhi: Phase II trials of the indigenously developed COVID-19 vaccine, Covaxin, is likely to begin on Monday, according to a media report on Sunday.
Covaxin has been developed by Hyderabad-based Bharat Biotech in collaboration with…